FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Buspirone HCl Tablets
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories:

Expand all

Accord Healthcare Inc. (New 11/21/2018)

Company Contact Information:
866-941-7875

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 16729-200-01) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug
5 mg, 500 count bottle (NDC 16729-200-16) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug
7.5 mg, 100 count bottle (NDC 16729-201-01) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug
10 mg, 100 count bottle (NDC 16729-202-01) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug
10 mg, 500 count bottle (NDC 16729-202-16) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug
15 mg, 60 count bottle (NDC 16729-203-12) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug
15 mg, 100 count bottle (NDC 16729-203-01) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug
30 mg, 60 count bottle (NDC 16729-289-12) Product under allocation. More supplies inbound. Stocks available to support current demand; Cannot support additional customers. Estimated shortage until Jan 2019. Market disruption leading to higher orders. Higher stock build-up from Jan onwards. Demand increase for the drug

Impax Laboratories (New 11/21/2018)

Company Contact Information:
877-994-6729

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0115-1690-01) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
5 mg, 500 count bottle (NDC 0115-1690-02) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
5 mg, 1000 count bottle (NDC 0115-1690-03) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
10 mg, 100 count bottle (NDC 0115-1691-01) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
10 mg, 500 count bottle (NDC 0115-1691-02) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
10 mg, 1000 count bottle (NDC 0115-1691-03) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
15 mg, 60 count bottle (NDC 0115-1692-13) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
15 mg, 180 count bottle (NDC 0115-1692-19) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug
15 mg, 500 count bottle (NDC 0115-1692-02) Unavailable This was a business-related decision to discontinue manufacturing these products

Link to Discontinuance

Discontinuation of the manufacture of the drug

Mylan Pharmaceuticals Inc. (Reverified 12/07/2018)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
7.5 mg, 100 count bottle (NDC 49884-725-01) Available Marketed by Par Pharmaceutical. For product availability inquiries, the number to call is 1-800-828-9393, option # 5 then option # 2
7.5 mg, 500 count bottle (NDC 49884-725-05) Available Marketed by Par Pharmaceutical. For product availability inquiries, the number to call is 1-800-828-9393, option # 5 then option # 2
5 mg, 100 count bottle (NDC 0378-1140-01) Out of stock. Re-supply: TBD Other
5 mg, 500 count bottle (NDC 0378-1140-05) Out of stock. Re-supply: TBD Other
5 mg, unit-dose blister pack, 100 count (NDC 51079-985-20) Out of stock. Re-supply: TBD Other
7.5 mg, 100 count bottle (NDC 0378-1145-01) Out of stock. Re-supply: TBD Other
10 mg, 100 count bottle (NDC 0378-1150-01) Out of stock. Re-supply: TBD Other
10 mg, 500 count bottle (NDC 0378-1150-05) Out of stock. Re-supply: TBD Other
10 mg, unit-dose blister pack, 100 count (NDC 51079-986-20) Out of stock. Re-supply: TBD Other
15 mg, 60 count bottle (NDC 0378-1165-91) Out of stock. Re-supply: TBD Other
15 mg, 180 count bottle (NDC 0378-1165-80) Out of stock. Re-supply: TBD Other
15 mg, 500 count bottle (NDC 0378-1165-05) Out of stock. Re-supply: TBD Other
15 mg, unit-dose blister pack, 100 count (NDC 51079-960-20) Out of stock. Re-supply: TBD Other
30 mg, 60 count bottle (NDC 0378-1175-91) Out of stock. Re-supply: TBD Other
30 mg, unit-dose blister pack, 100 count (NDC 51079-994-20) Out of stock. Re-supply: TBD Other

Strides Pharma Inc. (New 11/21/2018)

Company Contact Information:
855-273-0146

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 64380-741-06) Available
5 mg, 500 count bottle (NDC 64380-741-07) Currently out of stock. Estimated re-supply: December 2018 Demand increase for the drug
5 mg, 1000 count bottle (NDC 64380-741-08) Available
7.5 mg, 100 count bottle (NDC 64380-787-06) Available
10 mg, 100 count bottle (NDC 64380-742-06) Available
10 mg, 500 count bottle (NDC 64380-742-07) Available
10 mg, 1000 count bottle (NDC 64380-742-08) Currently out of stock. Estimated re-supply: February 2019 Demand increase for the drug
30 mg, 60 count bottle (NDC 64380-744-03) Currently no customer orders. Estimated supply date January 2019 Other

Teva Pharmaceuticals (Revised 11/30/2018)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0093-0053-01) Actively selling. There is no projected back order.
5 mg, 500 count bottle (NDC 0093-0053-05) Actively selling. There is no projected back order. Teva can support more in December.
10 mg, 100 count bottle (NDC 0093-0054-01) Actively selling. Will be recovered in December with supply Delay in shipping
10 mg, 500 count bottle (NDC 0093-0054-05) Actively selling. Will be recovered in December with supply Delay in shipping
15 mg, 100 count bottle (NDC 0093-1003-01) Actively selling. There is no projected back order.
15 mg, 500 count bottle (NDC 0093-1003-05) Actively selling. Will be recovered in December with supply. Delay in shipping
30 mg, 60 count bottle (NDC 0093-5200-06) Actively selling. Will be recovered in November with supply Delay in shipping
30 mg, 500 count bottle (NDC 0093-5200-05) Actively selling. Will be recovered in December with supply Delay in shipping

Zydus Pharmaceuticals USA Inc. (New 11/21/2018)

Company Contact Information:
877-993-8779

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 68382-180-01) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug
5 mg, 500 count bottle (NDC 68382-180-05) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug
10 mg, 100 count bottle (NDC 68382-181-01) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug
10 mg, 500 count bottle (NDC 68382-181-05) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug
15 mg, 100 count bottle (NDC 68382-182-01) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug
15 mg, 500 count bottle (NDC 68382-182-05) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug
30 mg, 60 count bottle (NDC 68382-183-14) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug
30 mg, 500 count bottle (NDC 68382-183-05) Available on allocation to our existing customers Zydus is experiencing an increase in demand, product is on allocation to its current committed customers. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English